Trials / Unknown
UnknownNCT01289730
Etanercept (Enbrel) in Undifferentiated Spondyloarthritis
An Open-label Study of Etanercept (Enbrel) Efficacy in Undifferentiated Spondyloarthritis
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study has the aim to investigate the efficacy and safety of etanercept in patients with active undifferentiated spondyloarthritis (uSpA) over the period of 520 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept | Etanercept 25 mg subcutaneously twice a week |
Timeline
- Start date
- 2002-02-01
- Primary completion
- 2003-09-01
- Completion
- 2012-05-01
- First posted
- 2011-02-04
- Last updated
- 2011-02-04
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01289730. Inclusion in this directory is not an endorsement.